Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 11.50
+0.10 (0.88%)
Last updated: Mar 5, 2026, 4:14 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €85.78 million as of March 5, 2026. Its market cap has increased by 318.21% in one year.
Market Cap
85.78M
Enterprise Value
83.91M
Revenue
8.09M
Ranking
n/a
PE Ratio
43.94
Stock Price
€11.50
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 85.78M, an increase of 458.12%. That is a compound annual growth rate of 54.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 85.78M | 33.33% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.47B |
| Laboratorios Farmaceuticos Rovi | 4.33B |
| Almirall | 2.77B |
| Faes Farma | 1.62B |
| Oryzon Genomics | 247.60M |
| Prim, S.A. | 232.27M |
| Atrys Health | 224.59M |
| Laboratorio Reig Jofre | 211.62M |